Cervical dysplasia in a patient with multiple sclerosis treated with natalizumab.
We describe one report of a cervical dysplasia in a patient receiving natalizumab for multiple sclerosis. Other cases were identified in the WHO's global individual case safety report database, VigiBase® . These data underline the importance of monitoring HPV infection in patients with MS treated with natalizumab.